With the grave health consequences of what is increasingly becoming staple diet overlooked, regulators and the government ...

Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 - - Tourmaline ...

Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the ...

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and $300 Million Private Placement Financing ...

Aurora Cannabis Inc. , the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in ...

U.S. Attruby net product revenue and as of April 25, 2025, 2,072 unique patient prescriptions written by 756 unique prescribers - Observational run-in study for ...